| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycolipid binding | 2.60e-08 | 49 | 74 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.56e-07 | 34 | 74 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.29e-07 | 70 | 74 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.46e-06 | 23 | 74 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 3.85e-06 | 29 | 74 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 7.52e-06 | 73 | 74 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.73e-05 | 14 | 74 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.10e-05 | 90 | 74 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | antigen binding | 7.43e-05 | 190 | 74 | 6 | GO:0003823 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.82e-05 | 196 | 74 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.19e-04 | 207 | 74 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.22e-04 | 208 | 74 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.29e-04 | 210 | 74 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.67e-04 | 29 | 74 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 2.01e-04 | 6 | 74 | 2 | GO:0030882 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 2.30e-04 | 149 | 74 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | phosphatase binding | 4.41e-04 | 264 | 74 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.61e-04 | 293 | 74 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | CEACAM5 PSAP MID2 MGAT4A MID1 CEACAM8 MKLN1 CEACAM6 SLC3A2 CEACAM1 | 8.19e-04 | 815 | 74 | 10 | GO:0042803 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A4 CEACAM5 CLCN3 SLC22A16 SCN4A CEACAM8 CEACAM6 ABCC11 HTR3D ATP10B PKD1L2 SLC3A2 CEACAM1 | 8.30e-04 | 1289 | 74 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.02e-03 | 310 | 74 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.03e-03 | 13 | 74 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A4 CEACAM5 CLCN3 SLC22A16 SCN4A CEACAM8 CEACAM6 ABCC11 HTR3D PKD1L2 SLC3A2 CEACAM1 | 1.25e-03 | 1180 | 74 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | sialic acid binding | 3.85e-03 | 25 | 74 | 2 | GO:0033691 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.75e-07 | 14 | 77 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.37e-07 | 15 | 77 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.37e-07 | 15 | 77 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 3.16e-07 | 16 | 77 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 4.12e-07 | 17 | 77 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 4.12e-07 | 17 | 77 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 5.28e-07 | 18 | 77 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.31e-07 | 20 | 77 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 8.63e-07 | 47 | 77 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.02e-06 | 21 | 77 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.95e-06 | 27 | 77 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.96e-06 | 32 | 77 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.77e-06 | 33 | 77 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 8.61e-06 | 35 | 77 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.20e-05 | 38 | 77 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.34e-05 | 39 | 77 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.20e-05 | 15 | 77 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.20e-05 | 15 | 77 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.38e-05 | 45 | 77 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.60e-05 | 46 | 77 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.60e-05 | 46 | 77 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.28e-05 | 17 | 77 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 3.35e-05 | 49 | 77 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 6.34e-05 | 21 | 77 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 6.34e-05 | 21 | 77 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 7.32e-05 | 22 | 77 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 7.47e-05 | 60 | 77 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | immune effector process | CD1B CEACAM5 CD5L CD22 FCN1 SANBR CEACAM6 FCN3 IL4R STAT4 CEACAM1 IL9R | 7.66e-05 | 859 | 77 | 12 | GO:0002252 |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 7.97e-05 | 61 | 77 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 8.40e-05 | 23 | 77 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 8.40e-05 | 23 | 77 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 9.57e-05 | 24 | 77 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 9.57e-05 | 24 | 77 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 9.57e-05 | 24 | 77 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 9.61e-05 | 497 | 77 | 9 | GO:0002697 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.08e-04 | 25 | 77 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.08e-04 | 25 | 77 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.29e-04 | 69 | 77 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.37e-04 | 70 | 77 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.52e-04 | 72 | 77 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of viral entry into host cell | 1.53e-04 | 28 | 77 | 3 | GO:0046597 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.53e-04 | 28 | 77 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.61e-04 | 73 | 77 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.70e-04 | 29 | 77 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.09e-04 | 31 | 77 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 2.25e-04 | 147 | 77 | 5 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.30e-04 | 32 | 77 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.30e-04 | 32 | 77 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.52e-04 | 33 | 77 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of viral life cycle | 2.52e-04 | 33 | 77 | 3 | GO:1903901 | |
| GeneOntologyBiologicalProcess | adaptive immune response | IGKV1-12 CD1B SANBR FCRL4 IGKV1D-43 IGKV1D-12 TRAV35 IL4R STAT4 CEACAM1 IL9R | 2.69e-04 | 838 | 77 | 11 | GO:0002250 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.75e-04 | 34 | 77 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.75e-04 | 34 | 77 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | 2.84e-04 | 241 | 77 | 6 | GO:0002377 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 2.85e-04 | 7 | 77 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 3.02e-04 | 86 | 77 | 4 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 3.75e-04 | 91 | 77 | 4 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.75e-04 | 91 | 77 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 3.80e-04 | 358 | 77 | 7 | GO:0015850 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 3.94e-04 | 166 | 77 | 5 | GO:0002698 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 4.08e-04 | 93 | 77 | 4 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 4.08e-04 | 93 | 77 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 4.42e-04 | 95 | 77 | 4 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 4.47e-04 | 40 | 77 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 4.60e-04 | 96 | 77 | 4 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.81e-04 | 41 | 77 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of opsonization | 4.87e-04 | 9 | 77 | 2 | GO:1903028 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.97e-04 | 98 | 77 | 4 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 5.17e-04 | 42 | 77 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 5.17e-04 | 42 | 77 | 3 | GO:0006910 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 5.41e-04 | 178 | 77 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | import into cell | SLC6A4 CEACAM5 CLCN3 CD22 FCN1 CEACAM8 MKLN1 CEACAM6 FCN3 SLC3A2 CEACAM1 SIRPG | 5.98e-04 | 1074 | 77 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | receptor internalization | 5.99e-04 | 182 | 77 | 5 | GO:0031623 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 6.00e-04 | 103 | 77 | 4 | GO:0048525 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 7.21e-04 | 47 | 77 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 7.21e-04 | 47 | 77 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of opsonization | 7.40e-04 | 11 | 77 | 2 | GO:1903027 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 8.15e-04 | 49 | 77 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 8.47e-04 | 410 | 77 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 8.64e-04 | 50 | 77 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | organic acid transport | 8.72e-04 | 412 | 77 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | complement activation, lectin pathway | 8.86e-04 | 12 | 77 | 2 | GO:0001867 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 9.69e-04 | 52 | 77 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | endocytosis | CEACAM5 CLCN3 CD22 FCN1 CEACAM8 MKLN1 CEACAM6 FCN3 CEACAM1 SIRPG | 9.81e-04 | 827 | 77 | 10 | GO:0006897 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.02e-03 | 53 | 77 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 1.04e-03 | 13 | 77 | 2 | GO:0071349 | |
| GeneOntologyBiologicalProcess | regulation of viral entry into host cell | 1.14e-03 | 55 | 77 | 3 | GO:0046596 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.20e-03 | 124 | 77 | 4 | GO:0001910 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 1.20e-03 | 124 | 77 | 4 | GO:0034109 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.20e-03 | 56 | 77 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.21e-03 | 213 | 77 | 5 | GO:0015718 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.27e-03 | 126 | 77 | 4 | GO:1903035 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.31e-03 | 127 | 77 | 4 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 1.35e-03 | 128 | 77 | 4 | GO:0050795 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.40e-03 | 59 | 77 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.43e-03 | 449 | 77 | 7 | GO:0002449 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.47e-03 | 60 | 77 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.56e-03 | 334 | 77 | 6 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.56e-03 | 334 | 77 | 6 | GO:0001894 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 1.57e-03 | 226 | 77 | 5 | GO:0050680 | |
| GeneOntologyCellularComponent | external side of plasma membrane | CD1B CEACAM5 CLCN3 CD22 FCN1 CEACAM6 ADAM29 FCRL4 FCN3 RS1 IL4R CEACAM1 IL9R | 5.93e-08 | 519 | 78 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | CD1B CEACAM5 CD5L CLCN3 CD22 MSLNL FCN1 CEACAM8 CEACAM6 ADAM29 FCRL4 FCN3 RS1 IL4R SLC3A2 CEACAM1 IL9R SIRPG | 1.02e-07 | 1111 | 78 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 3.15e-07 | 16 | 78 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | side of membrane | CD1B CEACAM5 CLCN3 CD22 FCN1 CEACAM8 CEACAM6 ADAM29 FCRL4 FCN3 RS1 IL4R CEACAM1 IL9R | 3.86e-06 | 875 | 78 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | apical plasma membrane | CEACAM5 CLCN3 PTPRH CEACAM8 CEACAM6 ABCC11 USH2A SLC3A2 CEACAM1 | 8.24e-05 | 487 | 78 | 9 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | CEACAM5 CLCN3 PTPRH CEACAM8 CEACAM6 ABCC11 USH2A SLC3A2 CEACAM1 | 3.53e-04 | 592 | 78 | 9 | GO:0045177 |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.59e-04 | 90 | 78 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | T cell receptor complex | 3.62e-04 | 163 | 78 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | vacuolar membrane | 6.00e-04 | 507 | 78 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC6A4 CD1B DMXL2 PSAP CLCN3 CEACAM8 MKLN1 CEACAM6 ABCC11 ATP10B BACE2 RAB3A CEACAM1 | 1.03e-03 | 1307 | 78 | 13 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SLC6A4 CD1B DMXL2 PSAP CLCN3 CEACAM8 MKLN1 CEACAM6 ABCC11 ATP10B BACE2 RAB3A CEACAM1 | 1.17e-03 | 1325 | 78 | 13 | GO:0012506 |
| GeneOntologyCellularComponent | secretory granule | DMXL2 PSAP CLCN3 FCN1 APAF1 CEACAM8 CEACAM6 SPACA5 BACE2 RAB3A CEACAM1 | 1.31e-03 | 1014 | 78 | 11 | GO:0030141 |
| GeneOntologyCellularComponent | azurophil granule membrane | 1.40e-03 | 59 | 78 | 3 | GO:0035577 | |
| GeneOntologyCellularComponent | lysosomal membrane | 1.68e-03 | 462 | 78 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.68e-03 | 462 | 78 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.97e-03 | 350 | 78 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | blood microparticle | 2.08e-03 | 144 | 78 | 4 | GO:0072562 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 2.50e-03 | 20 | 78 | 2 | GO:1905370 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.84e-03 | 157 | 78 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 3.03e-03 | 22 | 78 | 2 | GO:1905286 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.77e-03 | 170 | 78 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | collagen trimer | 4.37e-03 | 88 | 78 | 3 | GO:0005581 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.22e-06 | 21 | 55 | 4 | MP:0031415 | |
| MousePheno | decreased cellular glucose uptake | 1.95e-06 | 53 | 55 | 5 | MP:0003926 | |
| MousePheno | decreased fatty acid oxidation | 2.15e-06 | 24 | 55 | 4 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 3.52e-06 | 27 | 55 | 4 | MP:0009286 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 6.24e-06 | 31 | 55 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 6.24e-06 | 31 | 55 | 4 | MP:0008964 | |
| MousePheno | abnormal carbon dioxide production | 6.28e-06 | 67 | 55 | 5 | MP:0008962 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.03e-05 | 35 | 55 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.15e-05 | 36 | 55 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 1.59e-05 | 39 | 55 | 4 | MP:0030022 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 3.37e-05 | 47 | 55 | 4 | MP:0031617 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.77e-05 | 17 | 55 | 3 | MP:0031047 | |
| MousePheno | abnormal cellular glucose uptake | 4.88e-05 | 102 | 55 | 5 | MP:0003925 | |
| MousePheno | abnormal fatty acid oxidation | 5.86e-05 | 54 | 55 | 4 | MP:0010953 | |
| MousePheno | abnormal lipid oxidation | 9.48e-05 | 61 | 55 | 4 | MP:0010951 | |
| MousePheno | increased insulin secretion | 1.14e-04 | 64 | 55 | 4 | MP:0003058 | |
| MousePheno | insulin resistance | 1.18e-04 | 197 | 55 | 6 | MP:0005331 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.37e-04 | 67 | 55 | 4 | MP:0004130 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.76e-04 | 28 | 55 | 3 | MP:0020950 | |
| MousePheno | abnormal glycogen homeostasis | 2.49e-04 | 144 | 55 | 5 | MP:0005438 | |
| MousePheno | decreased oxygen consumption | 2.59e-04 | 79 | 55 | 4 | MP:0005290 | |
| MousePheno | polyphagia | 2.72e-04 | 80 | 55 | 4 | MP:0001433 | |
| MousePheno | ectrodactyly | 3.15e-04 | 7 | 55 | 2 | MP:0005230 | |
| MousePheno | abnormal response to infection | RNF123 CEACAM5 CD5L CLCN3 FCN1 CEACAM6 IL4R STAT4 CEACAM1 APOBEC3F | 4.11e-04 | 714 | 55 | 10 | MP:0005025 |
| MousePheno | abnormal response to antigen | RNF123 CEACAM5 CD5L CLCN3 FCN1 CEACAM6 IL4R STAT4 CEACAM1 APOBEC3F | 4.68e-04 | 726 | 55 | 10 | MP:0020000 |
| MousePheno | abnormal insulin secretion | 5.48e-04 | 171 | 55 | 5 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 6.25e-04 | 176 | 55 | 5 | MP:0014195 | |
| MousePheno | abnormal respiratory quotient | 6.58e-04 | 178 | 55 | 5 | MP:0004129 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 6.81e-04 | 44 | 55 | 3 | MP:0031023 | |
| MousePheno | abnormal pancreas secretion | 7.45e-04 | 183 | 55 | 5 | MP:0002694 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 7.64e-04 | 279 | 55 | 6 | MP:0009785 | |
| MousePheno | abnormal skeletal muscle morphology | 7.79e-04 | 508 | 55 | 8 | MP:0000759 | |
| MousePheno | decreased respiratory quotient | 9.09e-04 | 110 | 55 | 4 | MP:0010379 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 9.34e-04 | 49 | 55 | 3 | MP:0020948 | |
| MousePheno | abnormal oxygen consumption | 9.92e-04 | 195 | 55 | 5 | MP:0005288 | |
| MousePheno | obese | 1.01e-03 | 113 | 55 | 4 | MP:0001261 | |
| MousePheno | abnormal pancreatic beta cell physiology | 1.01e-03 | 196 | 55 | 5 | MP:0003562 | |
| MousePheno | abnormal muscle morphology | SLC6A4 ZMYND11 CEACAM5 PSAP HOXC13 HOXD13 SCN4A CEACAM8 CTHRC1 CEACAM6 LAMC1 CEACAM1 | 1.02e-03 | 1106 | 55 | 12 | MP:0002108 |
| MousePheno | abnormal susceptibility to infection | RNF123 CEACAM5 CD5L FCN1 CEACAM6 IL4R STAT4 CEACAM1 APOBEC3F | 1.13e-03 | 672 | 55 | 9 | MP:0001793 |
| MousePheno | abnormal endocrine pancreas physiology | 1.16e-03 | 202 | 55 | 5 | MP:0010147 | |
| MousePheno | decreased energy expenditure | 1.22e-03 | 119 | 55 | 4 | MP:0004890 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 1.26e-03 | 120 | 55 | 4 | MP:0009786 | |
| Domain | Ig-like_fold | CD1B CEACAM5 PTPRH MID2 CD22 UNC5B MID1 CEACAM8 CEACAM6 FCRL4 USH2A IL4R CEACAM1 IL9R SIRPG | 7.50e-08 | 706 | 73 | 15 | IPR013783 |
| Domain | - | CD1B CEACAM5 MID2 CD22 UNC5B MID1 CEACAM8 CEACAM6 FCRL4 USH2A IL4R CEACAM1 IL9R SIRPG | 2.35e-07 | 663 | 73 | 14 | 2.60.40.10 |
| Domain | Ig_2 | 4.00e-07 | 73 | 73 | 6 | PF13895 | |
| Domain | ig | 9.33e-06 | 190 | 73 | 7 | PF00047 | |
| Domain | Immunoglobulin | 9.33e-06 | 190 | 73 | 7 | IPR013151 | |
| Domain | IGc2 | 3.67e-05 | 235 | 73 | 7 | SM00408 | |
| Domain | Ig_sub2 | 3.67e-05 | 235 | 73 | 7 | IPR003598 | |
| Domain | HoxA13_N | 9.00e-05 | 4 | 73 | 2 | PF12284 | |
| Domain | HoxA13_N | 9.00e-05 | 4 | 73 | 2 | IPR022067 | |
| Domain | Ig_I-set | 9.90e-05 | 190 | 73 | 6 | IPR013098 | |
| Domain | I-set | 9.90e-05 | 190 | 73 | 6 | PF07679 | |
| Domain | IG_LIKE | 1.22e-04 | 491 | 73 | 9 | PS50835 | |
| Domain | FN3 | 1.28e-04 | 199 | 73 | 6 | PS50853 | |
| Domain | Ig-like_dom | 1.46e-04 | 503 | 73 | 9 | IPR007110 | |
| Domain | FN3_dom | 1.67e-04 | 209 | 73 | 6 | IPR003961 | |
| Domain | - | 1.91e-04 | 73 | 73 | 4 | 2.60.120.260 | |
| Domain | IG | 2.33e-04 | 421 | 73 | 8 | SM00409 | |
| Domain | Ig_sub | 2.33e-04 | 421 | 73 | 8 | IPR003599 | |
| Domain | SPRY | 3.74e-04 | 87 | 73 | 4 | SM00449 | |
| Domain | HEMATOPO_REC_S_F1 | 4.16e-04 | 8 | 73 | 2 | PS01355 | |
| Domain | SPRY | 5.02e-04 | 94 | 73 | 4 | PF00622 | |
| Domain | SPRY_dom | 5.02e-04 | 94 | 73 | 4 | IPR003877 | |
| Domain | Galactose-bd-like | 5.02e-04 | 94 | 73 | 4 | IPR008979 | |
| Domain | B30.2/SPRY | 5.23e-04 | 95 | 73 | 4 | IPR001870 | |
| Domain | B302_SPRY | 5.23e-04 | 95 | 73 | 4 | PS50188 | |
| Domain | Hempt_rcpt_S_F1_CS | 5.33e-04 | 9 | 73 | 2 | IPR003531 | |
| Domain | V-set | 7.68e-04 | 184 | 73 | 5 | PF07686 | |
| Domain | FN3 | 7.87e-04 | 185 | 73 | 5 | SM00060 | |
| Domain | COS_domain | 9.70e-04 | 12 | 73 | 2 | IPR017903 | |
| Domain | COS | 9.70e-04 | 12 | 73 | 2 | PS51262 | |
| Domain | Ig_V-set | 1.09e-03 | 199 | 73 | 5 | IPR013106 | |
| Domain | Bbox_C | 1.53e-03 | 15 | 73 | 2 | IPR003649 | |
| Domain | BBC | 1.53e-03 | 15 | 73 | 2 | SM00502 | |
| Domain | ConA-like_dom | 1.67e-03 | 219 | 73 | 5 | IPR013320 | |
| Domain | Laminin_N | 1.75e-03 | 16 | 73 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 1.75e-03 | 16 | 73 | 2 | PS51117 | |
| Domain | Laminin_N | 1.75e-03 | 16 | 73 | 2 | PF00055 | |
| Domain | LamNT | 1.75e-03 | 16 | 73 | 2 | SM00136 | |
| Domain | Fibrinogen_CS | 2.47e-03 | 19 | 73 | 2 | IPR020837 | |
| Domain | Butyrophylin | 2.60e-03 | 70 | 73 | 3 | IPR003879 | |
| Domain | WD40 | 3.44e-03 | 259 | 73 | 5 | PF00400 | |
| Domain | fn3 | 3.73e-03 | 162 | 73 | 4 | PF00041 | |
| Domain | Fibrinogen_a/b/g_C_2 | 3.93e-03 | 24 | 73 | 2 | IPR014715 | |
| Domain | - | 3.93e-03 | 24 | 73 | 2 | 4.10.530.10 | |
| Domain | WD40 | 3.98e-03 | 268 | 73 | 5 | SM00320 | |
| Domain | WD40_repeat | 4.24e-03 | 272 | 73 | 5 | IPR001680 | |
| Domain | SR | 4.26e-03 | 25 | 73 | 2 | SM00202 | |
| Domain | - | 4.26e-03 | 25 | 73 | 2 | 3.10.250.10 | |
| Domain | Collagen | 4.50e-03 | 85 | 73 | 3 | IPR008160 | |
| Domain | Collagen | 4.50e-03 | 85 | 73 | 3 | PF01391 | |
| Domain | SRCR_1 | 4.61e-03 | 26 | 73 | 2 | PS00420 | |
| Domain | SRCR_2 | 4.61e-03 | 26 | 73 | 2 | PS50287 | |
| Domain | SRCR-like_dom | 4.61e-03 | 26 | 73 | 2 | IPR017448 | |
| Domain | WD_REPEATS_1 | 4.64e-03 | 278 | 73 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.71e-03 | 279 | 73 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.71e-03 | 279 | 73 | 5 | PS50294 | |
| Domain | SRCR | 4.96e-03 | 27 | 73 | 2 | IPR001190 | |
| Domain | Fibrinogen_C | 4.96e-03 | 27 | 73 | 2 | PF00147 | |
| Domain | FBG | 5.71e-03 | 29 | 73 | 2 | SM00186 | |
| Domain | - | 6.11e-03 | 30 | 73 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 6.11e-03 | 30 | 73 | 2 | IPR014716 | |
| Domain | EGF_LAM_2 | 6.11e-03 | 30 | 73 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 6.11e-03 | 30 | 73 | 2 | PS01248 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | IGKV1-12 CEACAM5 CEACAM8 CEACAM6 IGKV1D-16 IGKV1D-12 SLC3A2 CEACAM1 SIRPG | 6.38e-08 | 194 | 56 | 9 | M16312 |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 1.18e-06 | 6 | 56 | 3 | M26970 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 8.79e-06 | 71 | 56 | 5 | M1078 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.58e-05 | 80 | 56 | 5 | M6121 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 3.68e-05 | 158 | 56 | 6 | MM14812 | |
| Pathway | REACTOME_HEMOSTASIS | IGKV1-12 CEACAM5 PSAP CEACAM8 CEACAM6 IGKV1D-16 IGKV1D-12 KLKB1 SLC3A2 CEACAM1 SIRPG | 6.11e-05 | 679 | 56 | 11 | M8395 |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 9.08e-05 | 115 | 56 | 5 | M19752 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 9.85e-05 | 61 | 56 | 4 | M27581 | |
| Pathway | REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE | 1.54e-04 | 5 | 56 | 2 | M27204 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 1.67e-04 | 511 | 56 | 9 | MM15330 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE | 2.30e-04 | 6 | 56 | 2 | M47785 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 3.72e-04 | 86 | 56 | 4 | M601 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 3.89e-04 | 87 | 56 | 4 | M6856 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 4.27e-04 | 8 | 56 | 2 | M27005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN | 4.27e-04 | 8 | 56 | 2 | M47784 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 6.35e-04 | 99 | 56 | 4 | MM14624 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN | 6.83e-04 | 10 | 56 | 2 | M47879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 8.33e-04 | 11 | 56 | 2 | M47874 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 9.24e-04 | 190 | 56 | 5 | M8240 | |
| Pathway | REACTOME_HEMOSTASIS | 1.76e-03 | 571 | 56 | 8 | MM14472 | |
| Pubmed | 2.47e-11 | 4 | 79 | 4 | 26483485 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 25409014 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17167768 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 31171910 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 28567513 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 8207827 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 11994468 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 2.43e-08 | 14 | 79 | 4 | 27161904 | |
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 20381490 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 23070997 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 10491101 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 22159884 | ||
| Pubmed | 3.30e-08 | 15 | 79 | 4 | 24948196 | ||
| Pubmed | 3.30e-08 | 15 | 79 | 4 | 20410265 | ||
| Pubmed | 3.30e-08 | 15 | 79 | 4 | 26586918 | ||
| Pubmed | Activation of CEA-CAM-1-mediated cell adhesion via CD98: involvement of PKCdelta. | 3.30e-08 | 15 | 79 | 4 | 14527684 | |
| Pubmed | 4.39e-08 | 16 | 79 | 4 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 4.39e-08 | 16 | 79 | 4 | 11284729 | |
| Pubmed | Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. | 4.50e-08 | 4 | 79 | 3 | 19077207 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 10436421 | ||
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 4.50e-08 | 4 | 79 | 3 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 4.50e-08 | 4 | 79 | 3 | 27748756 | |
| Pubmed | A secreted protein microarray platform for extracellular protein interaction discovery. | 1.15e-07 | 51 | 79 | 5 | 21982860 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 9.25e-07 | 77 | 79 | 5 | 16944957 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 3.17e-06 | 13 | 79 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 3.17e-06 | 13 | 79 | 3 | 1985902 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 10964771 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 3.17e-06 | 13 | 79 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 3.17e-06 | 13 | 79 | 3 | 16638824 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 20044046 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 32150576 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 22469976 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 3.17e-06 | 13 | 79 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 3.17e-06 | 13 | 79 | 3 | 28035001 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 3.17e-06 | 13 | 79 | 3 | 12832451 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 3.17e-06 | 13 | 79 | 3 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 3.17e-06 | 13 | 79 | 3 | 21670291 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 3.17e-06 | 13 | 79 | 3 | 23935487 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 2702644 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 8380065 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 1279194 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 15331748 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 3.17e-06 | 13 | 79 | 3 | 22406619 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 7628460 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 25724769 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 3.17e-06 | 13 | 79 | 3 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 3.17e-06 | 13 | 79 | 3 | 22092845 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 11801635 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 28913658 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 19008452 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 3.17e-06 | 13 | 79 | 3 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 3.17e-06 | 13 | 79 | 3 | 8500759 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 3.17e-06 | 13 | 79 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 3.17e-06 | 13 | 79 | 3 | 23800882 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 15207636 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 19285068 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 21760897 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 3.17e-06 | 13 | 79 | 3 | 1326665 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 21081647 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 3.17e-06 | 13 | 79 | 3 | 39168268 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 11483763 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 8402684 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 2164599 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 16619040 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 3.17e-06 | 13 | 79 | 3 | 8209741 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 3.17e-06 | 13 | 79 | 3 | 21949477 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 29396368 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 26219866 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 18003729 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 26284027 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 2133556 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 3.17e-06 | 13 | 79 | 3 | 33352461 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 19406938 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 38381498 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 20739537 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 3.17e-06 | 13 | 79 | 3 | 29967450 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 3.17e-06 | 13 | 79 | 3 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 3.17e-06 | 13 | 79 | 3 | 27695943 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 20404914 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 16680193 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 26911181 | ||
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 3.17e-06 | 13 | 79 | 3 | 32027621 | |
| Pubmed | 3.17e-06 | 13 | 79 | 3 | 30664851 | ||
| Interaction | CEACAM1 interactions | 9.56e-07 | 21 | 74 | 4 | int:CEACAM1 | |
| Interaction | CEACAM6 interactions | 7.14e-06 | 34 | 74 | 4 | int:CEACAM6 | |
| Interaction | CEACAM5 interactions | 1.68e-05 | 14 | 74 | 3 | int:CEACAM5 | |
| Cytoband | 2p12 | 5.19e-05 | 117 | 79 | 4 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 5.16e-04 | 213 | 79 | 4 | chr2p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 1.19e-03 | 120 | 79 | 3 | chr17q23 | |
| Cytoband | 17q23.3 | 1.23e-03 | 30 | 79 | 2 | 17q23.3 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CD1B CEACAM5 CD22 CEACAM8 CEACAM6 FCRL4 IL4R CEACAM1 IL9R SIRPG | 8.44e-07 | 394 | 62 | 10 | 471 |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 1.27e-06 | 24 | 62 | 4 | 906 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.88e-04 | 83 | 62 | 4 | 351 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.39e-04 | 163 | 62 | 5 | 590 | |
| GeneFamily | Immunoglobulin like domain containing | 5.20e-04 | 193 | 62 | 5 | 594 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 1.71e-03 | 18 | 62 | 2 | 498 | |
| GeneFamily | WD repeat domain containing | 2.03e-03 | 262 | 62 | 5 | 362 | |
| GeneFamily | Fibronectin type III domain containing | 2.21e-03 | 160 | 62 | 4 | 555 | |
| GeneFamily | Fibrinogen C domain containing | 3.30e-03 | 25 | 62 | 2 | 554 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.71e-03 | 41 | 62 | 2 | 1298 | |
| GeneFamily | C1-set domain containing | 9.12e-03 | 42 | 62 | 2 | 591 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 9.12e-03 | 42 | 62 | 2 | 602 | |
| GeneFamily | HOXL subclass homeoboxes | 1.37e-02 | 52 | 62 | 2 | 518 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 5.98e-06 | 75 | 73 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | rectum | 2.46e-05 | 168 | 73 | 6 | rectum | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_500 | 3.86e-05 | 110 | 73 | 5 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_500 | 4.18e-05 | 373 | 73 | 8 | gudmap_developingLowerUrinaryTract_adult_ureter_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_200 | 1.64e-04 | 31 | 73 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_500 | 1.84e-04 | 82 | 73 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_500 | 1.84e-04 | 82 | 73 | 4 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k5 | |
| CoexpressionAtlas | colon | 2.20e-04 | 159 | 73 | 5 | colon | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.33e-04 | 161 | 73 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.60e-08 | 199 | 79 | 7 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_intermediate|ICU-SEP / Disease, Lineage and Cell Type | 6.10e-07 | 171 | 79 | 6 | 2e44bf6f3d90193e7cadcac48bb852bd632a81bc | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.97e-07 | 179 | 79 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.23e-07 | 180 | 79 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.23e-07 | 180 | 79 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.35e-07 | 184 | 79 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.96e-07 | 186 | 79 | 6 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.96e-07 | 186 | 79 | 6 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-06 | 190 | 79 | 6 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-06 | 192 | 79 | 6 | 935a4a36881a9fa4daa02cba96af07f6686ed8d6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-06 | 193 | 79 | 6 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-06 | 193 | 79 | 6 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-06 | 193 | 79 | 6 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-06 | 194 | 79 | 6 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-06 | 199 | 79 | 6 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | Endothelial_cells-Endothelial-A|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.48e-06 | 199 | 79 | 6 | 2a1424c61ddcd1fea9574f7a3ad1955387458130 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|Control_saline / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 199 | 79 | 6 | e1240bfcdce76ec018599c50350748f9c7b8fb0e | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-06 | 199 | 79 | 6 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.84e-06 | 153 | 79 | 5 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.84e-06 | 153 | 79 | 5 | e9d6b4e895ddb8d6e6c8b043da591ec11365e124 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-06 | 155 | 79 | 5 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 159 | 79 | 5 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 167 | 79 | 5 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 171 | 79 | 5 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | Int-URO-Lymphocyte-B-B_memory|Int-URO / Disease, Lineage and Cell Type | 1.38e-05 | 172 | 79 | 5 | 38ebfb060c1c9ce9dea6b5833051c5bccb687e29 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Opalin_(Opalin)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 82 | 79 | 4 | 5cd8e47edb775eabf3e9a407c1c2d8a78afb9509 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 82 | 79 | 4 | 1eeb259ec555879ee1962b7bc2c31c200fbb85cf | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 174 | 79 | 5 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 174 | 79 | 5 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-05 | 179 | 79 | 5 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.86e-05 | 183 | 79 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 185 | 79 | 5 | e29079ef09aee62c3e9756341db4e59ca9dbf7ac | |
| ToppCell | facs-Large_Intestine-Distal-24m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 185 | 79 | 5 | 2ecc4b76b3645b65c226c2298bff307cc6479172 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.17e-05 | 189 | 79 | 5 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-05 | 189 | 79 | 5 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.23e-05 | 190 | 79 | 5 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-05 | 191 | 79 | 5 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 191 | 79 | 5 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.34e-05 | 192 | 79 | 5 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.34e-05 | 192 | 79 | 5 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 2.34e-05 | 192 | 79 | 5 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.46e-05 | 194 | 79 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 194 | 79 | 5 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.52e-05 | 195 | 79 | 5 | b0dbaae86f5703ab62f925e0f36500274044884a | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-05 | 195 | 79 | 5 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-05 | 197 | 79 | 5 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-05 | 197 | 79 | 5 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.65e-05 | 197 | 79 | 5 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 197 | 79 | 5 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 197 | 79 | 5 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.65e-05 | 197 | 79 | 5 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.65e-05 | 197 | 79 | 5 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-05 | 198 | 79 | 5 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.72e-05 | 198 | 79 | 5 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | LAM-Endothelial-VasEndo-2|Endothelial / Condition, Lineage and Cell class | 2.72e-05 | 198 | 79 | 5 | 92bccaec01f1dbb17d5efcba30f7f800f674ca96 | |
| ToppCell | COVID-19_Severe-Neu_4|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 2.72e-05 | 198 | 79 | 5 | bfdddddef9f3f0eb6af013873dec4e06b7c78c58 | |
| ToppCell | COVID-19_Severe-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.78e-05 | 199 | 79 | 5 | 0e327479bbda5a16643cf317d293a2918d619f87 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 2.78e-05 | 199 | 79 | 5 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-05 | 199 | 79 | 5 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 2.78e-05 | 199 | 79 | 5 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 2.78e-05 | 199 | 79 | 5 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.78e-05 | 199 | 79 | 5 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 2.78e-05 | 199 | 79 | 5 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-05 | 200 | 79 | 5 | cad2d972aa6ea0cc9ebe5ec60fda6e306e9ee2b2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.85e-05 | 200 | 79 | 5 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | (52)_cycling_DCs|World / shred on Cell_type and subtype | 2.92e-05 | 201 | 79 | 5 | ad2d25d84345fdd593065516a05c5c2b5429eac0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 145 | 79 | 4 | c0894c738815ff54790caddb4bccfa1503fd555b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 147 | 79 | 4 | 463af96748349c8fec2911b353a7e7e4cb072280 | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 1.43e-04 | 149 | 79 | 4 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 156 | 79 | 4 | 4f92ca30755430db44402afc603d1ecd8bfc3617 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 156 | 79 | 4 | 0de2fc695bd5f8d4633c514f71ea941c88137bac | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 159 | 79 | 4 | a6093b230afdd4d91870d289c6ac91d1856666a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.93e-04 | 161 | 79 | 4 | 1b5ebc82ee6166ecc2984648565f334cd69b636b | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 162 | 79 | 4 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 162 | 79 | 4 | 30508c4007faa38b76246e3c6d7b3fde4492cc85 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 162 | 79 | 4 | 33b73c6727b5c5ada2dddf304f56d84397725ca8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-04 | 162 | 79 | 4 | b46158e260bd2f35702cec73e3b035e8e9ec4469 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 162 | 79 | 4 | 44ef0932ee38964ff11edc2aa14698d9db3b2b6b | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 162 | 79 | 4 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 162 | 79 | 4 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.16e-04 | 166 | 79 | 4 | a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.16e-04 | 166 | 79 | 4 | c64971c27cb445dffc5a636d4b6a60261b93a2db | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 166 | 79 | 4 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 166 | 79 | 4 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.16e-04 | 166 | 79 | 4 | 2f3072a7af048f184d33065fdd36153fd563155a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 166 | 79 | 4 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-04 | 166 | 79 | 4 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.16e-04 | 166 | 79 | 4 | 188f2575511f418216874aed9118aa6f165252cb | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-04 | 167 | 79 | 4 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 169 | 79 | 4 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 169 | 79 | 4 | d2def7229fe9d6b0c70cfed349ede491c8c137a0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.32e-04 | 169 | 79 | 4 | 0ee74cc97a2db9cc16dc73424f74747afe13af90 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.37e-04 | 170 | 79 | 4 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.37e-04 | 170 | 79 | 4 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 2.37e-04 | 170 | 79 | 4 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 2.37e-04 | 170 | 79 | 4 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.37e-04 | 170 | 79 | 4 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 2.37e-04 | 170 | 79 | 4 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| Disease | Fc receptor-like protein 3 measurement | 3.51e-05 | 4 | 72 | 2 | EFO_0008127 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 8.75e-05 | 6 | 72 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | Eye Abnormalities | 7.80e-04 | 17 | 72 | 2 | C0015393 | |
| Disease | uridine diphosphate measurement | 1.08e-03 | 20 | 72 | 2 | EFO_0010545 | |
| Disease | serum carcinoembryonic antigen measurement | 1.08e-03 | 20 | 72 | 2 | EFO_0005760 | |
| Disease | Tinnitus, wellbeing measurement | 1.69e-03 | 96 | 72 | 3 | EFO_0007869, HP_0000360 | |
| Disease | pancreatic cancer (is_marker_for) | 1.96e-03 | 101 | 72 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Early Pregnancy Loss | 2.43e-03 | 109 | 72 | 3 | C3830362 | |
| Disease | Miscarriage | 2.43e-03 | 109 | 72 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 2.43e-03 | 109 | 72 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 2.43e-03 | 109 | 72 | 3 | C0000822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNSTQKQSSYVGWWI | 181 | Q9UKF5 | |
| WWNVVTGESSQTFYT | 1201 | O14727 | |
| WSCAWSLNIQANNCF | 286 | Q8WV16 | |
| QLACWTNSETPWSYF | 341 | Q9Y5Z0 | |
| SWSSSAYQAWAQEAG | 86 | Q2NKJ3 | |
| SWTPNYKQCSWSSLN | 101 | Q96CG8 | |
| TQDATYLWWVNNQSL | 171 | P06731 | |
| TQNTTYLWWVNGQSL | 171 | P31997 | |
| YTWNGNILSISNKSW | 136 | Q96PJ5 | |
| QNQWYTVCQTGWSLR | 156 | O43866 | |
| EWSNVTSSQYDWSQP | 1951 | Q8TDJ6 | |
| TQWAESGYSSQWCYE | 886 | O60231 | |
| FTNSTWAQTQGSGWL | 36 | P29016 | |
| WASTQPDWIAICYNN | 321 | P61962 | |
| QQWNNATWTEVSYTF | 206 | Q9NRD1 | |
| EWTQYQCLSFSARWA | 476 | O94823 | |
| FNSSTWNFCSQNWSQ | 391 | O75355 | |
| NSWVCYSATTHRWSP | 1281 | Q68CQ1 | |
| NAVQDWSTQIKTYSW | 111 | P20336 | |
| WSTQIKTYSWDNAQV | 116 | P20336 | |
| SNSNCAVIVHGAWWY | 241 | O75636 | |
| TSFLTLSWYTTWQNG | 16 | Q9UM21 | |
| NSWVWTCQAKPDSNY | 321 | Q9HBG6 | |
| SSEYGIFQLNSAWWC | 71 | Q96QH8 | |
| RASQGISSWLAWYQQ | 46 | P01611 | |
| WASQGISSYLAWYQQ | 46 | A0A0B4J1Z2 | |
| VQNTTYLWWVNGQSL | 171 | P40199 | |
| WLSYWLEQGSGTNSS | 826 | Q96J66 | |
| ILWSGWASNSNYALI | 116 | P03886 | |
| WASANCSLLQGFWCQ | 51 | Q96KJ4 | |
| WYLSASSAELQQQWL | 681 | Q5JSP0 | |
| CQDTQGNWYDWTQCI | 566 | O95402 | |
| WLNSSCAWSESSQLN | 411 | Q9NYZ3 | |
| VAAECSTWNYFWQQV | 176 | Q9H8H3 | |
| WNATTLSEWQYQSQD | 2071 | Q7Z442 | |
| TVTWTWQGYTFIQLC | 256 | Q7L5N7 | |
| SSSNCAEKFQGAWWY | 266 | O00602 | |
| NTNYEVTWYTSWSPC | 266 | Q8IUX4 | |
| QCYNTTWSEWSPSTK | 206 | P24394 | |
| TQDTTYLWWINNQSL | 171 | P13688 | |
| WWESNNYQSFCLPSE | 676 | Q86WJ1 | |
| SWTLANGWNSQVYCT | 231 | P35453 | |
| QYLNATGNRWCSWSL | 421 | P08195 | |
| HWALSNGWDSQVYCS | 216 | P31276 | |
| STIYTNCWVTGWGFS | 511 | P03952 | |
| RASQGISSWLAWYQQ | 46 | A0A0C4DH73 | |
| LTDYNNQADTTWWQS | 106 | P11047 | |
| SLNLWYDCTWNNDTK | 36 | P54852 | |
| ILTYCSWPQGNSWNQ | 36 | Q6ICI0 | |
| SWPQGNSWNQSCVTF | 41 | Q6ICI0 | |
| STYTWSWNVCQELLS | 376 | Q8N7B9 | |
| CWVNNSIGQTASKAW | 571 | P20273 | |
| NASSCYTLSWVNTRW | 351 | Q5JXM2 | |
| YTWNSAGHTCSSWNV | 4241 | O75445 | |
| NTTWYSNDTWYGNDT | 291 | P35499 | |
| NSFWIYDIVRNSWSC | 546 | Q9UL63 | |
| YDQNTWKSTAVTQWN | 131 | Q86VW1 | |
| SSGGTNYSRSWNDWQ | 11 | Q6P435 | |
| SWGYFNTQSQSWNVE | 201 | Q9UHJ6 | |
| YTGQWSEWSQPVCFQ | 241 | Q01113 | |
| WGTINWLTCSRCYQA | 391 | Q6NSI8 | |
| GTYNWTSWFLVNISD | 306 | Q9P1W8 | |
| SNTISQCGWSASANW | 146 | Q70Z44 | |
| WSDGSNSQYRNWYTD | 121 | Q9H9P2 | |
| WYNHEQCCWGSNETT | 166 | P51790 | |
| WLPICSSNWNDSYSE | 246 | Q9BYE2 | |
| WNVTTTNYGKAWAAG | 181 | Q5XPI4 | |
| PNAWASIIWYNVSTN | 461 | Q14765 | |
| SWNKNWQTGAAQDCS | 206 | A6NH21 | |
| NSASWALCRCNNNWV | 571 | O15344 | |
| SNYNYVNWWSTAQSL | 196 | Q8WW62 | |
| CGTALYNNLLWSNWS | 221 | Q9UH36 | |
| CTSSSIFNTWLWYKQ | 41 | P0DPF4 | |
| IWGPSYWCQNTETAA | 496 | P07602 | |
| YWCQCVAWSSAGTTK | 126 | Q8IZJ1 | |
| WNTSYCSIKCQQEHW | 576 | Q15326 | |
| FTGQANFISKSWCSW | 441 | Q9UJV3 | |
| GWYSSWTANKARLNS | 91 | O15537 | |
| FTDQLPWTSCKNSWN | 191 | P31645 | |
| VSSYQHWIWDCLNGQ | 346 | Q9UI38 | |
| ANWVNQTSRTNETWY | 616 | Q9HD43 | |
| WTNRVWSIYSWCQNC | 76 | Q96HE9 | |
| WSIYSWCQNCITQSL | 81 | Q96HE9 | |
| SSCISGNNFSWSLQW | 241 | Q309B1 | |
| RASQGISSWLAWYQQ | 46 | P01601 |